Table 1.

Affected Functions of Cytokine-Stimulated HUVEC Identified by DD/RT-PCR

Gene Product Expression*Accession No.Primer Pair
Leukocyte Trafficking  
MCP-1 (small inducible cytokine A2)  (E)  GB:X14768  AG3, CT3, GT3  
GM-CSF (CSF2)  (L)  GB:M11220  AG7, GA7 
Interleukin-8  (E)  GB:M28130  GC3  
RANTES (small inducible cytokine A5)  (L)  GB:M21121  AC6 
PCTA-1  (L)  GB:L78132  CC12 
Apoptosis/Cell Proliferation  
A20: TNF-α–inducible transcriptional factor  (E) GB:M59465  AA4, AG4  
Novel transcript CA2_1 (hIAP-1, U45878(E)  This study  AC2, CA2, GC2  
Novel cDNA AG8_1 (stannin)  (E)  This study  AG8  
BTG-1 antiproliferative protein  (E)  GB:H70177  CG11  
GSPT1 G to S phase transition  (R)  GB:X17644  AT7  
RGS-5 Regulator of G-protein signaling  (R)  GB:AB008109  CA2 
Protection Against Oxidative Damage  
Manganese superoxide dismutase  (L)  GB:X07834  GA12 
Ferritin heavy-chain  (REG)  GB:M97164  CC5 
Signaling/Regulation of Transcription  
GBP-2 interferon-induced  (L) GB:M55542  CC10  
SUPT4H  (L)  GB:U43923  CG11 
Fibrillarin  (REG)  GB:X56597  GA4  
TRIP7 (E)  GB:L40357  CT8  
Cell Shape/Cytoskeleton  
Myosin light chain (alkali isoform) (E)  GB:M22919  AA6  
GRAVIN  (REG) GB:AB003476  GG11  
Vesicular Transport  
Annexin-XI  (REG)  GB:L19605  GG1 
RAC1  (L)  GB:M29870  GG9  
Novel cDNA GG10_2 (Rabkinesin-6)  (R)  This study  GG10 
Thrombosis/Hemostasis  
Tissue factor  (E)  GB:M27436  CACA  
TFPI-2 (PP5) (L)  GB:L27624  GG12 
Unassigned  
COX-2 (prostaglandin G/H synthase)  (REG)  GB:D28235  GG11  
Ribosomal protein S11  (REG)  GB:X06617  GA2  
Novel cDNA GG2_1  (E) This study  GG2  
Novel cDNA CG12_1 (APOL-like)  (L) This study  CG12 
Gene Product Expression*Accession No.Primer Pair
Leukocyte Trafficking  
MCP-1 (small inducible cytokine A2)  (E)  GB:X14768  AG3, CT3, GT3  
GM-CSF (CSF2)  (L)  GB:M11220  AG7, GA7 
Interleukin-8  (E)  GB:M28130  GC3  
RANTES (small inducible cytokine A5)  (L)  GB:M21121  AC6 
PCTA-1  (L)  GB:L78132  CC12 
Apoptosis/Cell Proliferation  
A20: TNF-α–inducible transcriptional factor  (E) GB:M59465  AA4, AG4  
Novel transcript CA2_1 (hIAP-1, U45878(E)  This study  AC2, CA2, GC2  
Novel cDNA AG8_1 (stannin)  (E)  This study  AG8  
BTG-1 antiproliferative protein  (E)  GB:H70177  CG11  
GSPT1 G to S phase transition  (R)  GB:X17644  AT7  
RGS-5 Regulator of G-protein signaling  (R)  GB:AB008109  CA2 
Protection Against Oxidative Damage  
Manganese superoxide dismutase  (L)  GB:X07834  GA12 
Ferritin heavy-chain  (REG)  GB:M97164  CC5 
Signaling/Regulation of Transcription  
GBP-2 interferon-induced  (L) GB:M55542  CC10  
SUPT4H  (L)  GB:U43923  CG11 
Fibrillarin  (REG)  GB:X56597  GA4  
TRIP7 (E)  GB:L40357  CT8  
Cell Shape/Cytoskeleton  
Myosin light chain (alkali isoform) (E)  GB:M22919  AA6  
GRAVIN  (REG) GB:AB003476  GG11  
Vesicular Transport  
Annexin-XI  (REG)  GB:L19605  GG1 
RAC1  (L)  GB:M29870  GG9  
Novel cDNA GG10_2 (Rabkinesin-6)  (R)  This study  GG10 
Thrombosis/Hemostasis  
Tissue factor  (E)  GB:M27436  CACA  
TFPI-2 (PP5) (L)  GB:L27624  GG12 
Unassigned  
COX-2 (prostaglandin G/H synthase)  (REG)  GB:D28235  GG11  
Ribosomal protein S11  (REG)  GB:X06617  GA2  
Novel cDNA GG2_1  (E) This study  GG2  
Novel cDNA CG12_1 (APOL-like)  (L) This study  CG12 
*

Expression kinetics are indicated as follows: E, early genes show peak expression at 1.5 to 3 hours; L, expression of delayed early (3 to 6 hours) and late genes (6 to 20 hours); REG, genes that are expressed relatively abundantly in resting cells, but are upregulated twofold to fourfold; R, repressed genes.

Genbank accession number for obtaining full name, sequence, and references to published reports.

Primer pair represents the combination of anchored primer (letters) and decamer (number) that identified this gene during DD/RT-PCR, as described in Fig 2 and Bauer et al.15 

Close Modal

or Create an Account

Close Modal
Close Modal